Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Current Geriatrics Reports
Erschienen in: Current Geriatrics Reports 4/2018

03.10.2018 | Dermatology and Wound Care (C Sayed and D Culton, Section Editors)

Skin Disease and Neurological Conditions of the Elderly

verfasst von: John Tanaka, Christopher Henderson, Matilda W. Nicholas

Erschienen in: Current Geriatrics Reports | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Summarize and review the body of literature associating neurological diseases of the elderly with cutaneous disease.

Recent Findings

A growing body of evidence supports a close association between Parkinson’s disease and seborrheic dermatitis or rosacea, as well as a higher risk of melanoma. Development of bullous pemphigoid has also been found to be at higher incidence in those with multiple sclerosis. In some cases, skin disease may suggest early diagnosis of a developing neurologic condition, while in others, presence of a neurologic condition should prompt careful evaluation for cutaneous disease.

Summary

Elderly patients with neurodegenerative conditions should prompt evaluation for both benign facial dermatologic disease and bullous disease. Further research might elicit antigenic cross-reactivity between CNS epitopes and those in the skin.
Literatur
1.
Hurko O, Provost TT. Neurology and the skin. J Neurol Neurosurg Psychiatry. 1999;66:417–30.CrossRef
2.
Murray CJL, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2917–223.
3.
Van Den Eeden SK, Tanner CM, Bernstein AL, Fross RD, Leimpeter A, Bloch DA, et al. Incidence of Parkinson’s disease: variation by age, gender, and race/ethnicity. Am J Epidemiol. 2003;157:1015–22.CrossRef
4.
Galvan A, Wichmann T. Pathophysiology of Parkinsonism. Clin Neurophysiol. 2008;119(7):1459–74.CrossRef
5.
Ravn A-H, Thyssen JP, Egeberg A. Skin disorders in Parkinson’s disease: potential biomarkers and risk factors. Clin Cosmet Investig Dermatol. 2017;10:87–92.CrossRef
6.
de Lau LM, Breteler MM. Epidemiology of Parkinson’s disease. Lancet Neurol. 2006;5:525–35.CrossRef
7.
Chaudhuri KR, Schapira AH. Non-motor symptoms of Parkinson’s disease: dopaminergic pathophysiology and treatment. Lancet Neurol. 2009;8:464–74.CrossRef
8.
Gregory R, Miller S. Parkinson’s disease and the skin. Pract Neurol. 2015;15:246–9.CrossRef
9.
Gupta AK, Madzia SE, Batra R. Etiology and management of seborrheic dermatitis. Dermatology. 2004;208:89–93.CrossRef
10.
Arsic Arsenijevic VS, Milobratovic D, Barac AM, Vekic B, Marinkovic J, Kostic VS. A laboratory-based study on patients with Parkinson’s disease and seborrheic dermatitis: the presence and density of Malassezia yeasts, their different species and enzymes production. BMC Dermatol. 2014;14:5.CrossRef
11.
Braak H, Del Tredici K. Non-dopaminergic pathology of Parkinson’s disease. In: Olanow CW, Stocchi F, Lang AE, editors. Parkinson’s disease; 2011.
12.
• Tanner C, Albers K, Goldman S, Fross R, Leimpeter A, Klingman J, et al. Seborrheic dermatitis and risk of future Parkinson’s disease (PD)(S42. 001). Neurology. 2012;78(1 Supplement):S42–001 Retrospective review study which demonstrates that diagnosis of seborrheic dermatitis can precede and signal eventual diagnosis of Parkinson’s disease.
13.
Burton JL, Cartlidge M, Cartlidge NEF, Shuster S. Sebum excretion in Parkinsonism. Br J Dermatol. 1973;88:263–6.CrossRef
14.
Burton JL, Shuster S. Effect of L-Dopa on seborrhœa of Parkinsonism. Lancet. 1970;2(7662):19–20.CrossRef
15.
Cowley NC, Farr RM, Shuster S. The permissive effect of sebum in seborrhoeic dermatitis: an explanation of the rash in neurological disorders. Br J Dermatol. 1990;122:71–6.CrossRef
16.
17.
Steinhoff M, Buddenkotte J, Aubert J, et al. Clinical, cellular, and molecular aspects in the pathophysiology of rosacea. J Investig Dermatol Symp Proc. 2011;15:2–11.CrossRef
18.
Egeberg A, Hansen PR, Gislason GH, Thyssen JP. Exploring the association between rosacea and Parkinson disease: a Danish nationwide cohort study. JAMA Neurol. 2016;73(5):529–34.CrossRef
19.
Lyon S, Majewski S, Guido N, Ibler E, Huynh T, Rangel S, et al. LB766 Parkinson’s disease association with rosacea: a large, single center, retrospective study. J Investig Dermatol. 2016;136:B3.CrossRef
20.
Mathieu RJ, Guido N, Ibler E, Serrano L, Rangel SM, Schlosser BJ, et al. Rosacea and subsequent diagnosis for Parkinson’s disease: a large, urban, single center, US patient population retrospective study. J Eur Acad Dermatol Venereol. 2018;32(4):e141–4.CrossRef
21.
Chen X, Feng D, Schwarzschild MA, Gao X. Red hair, MC1R variants, and risk for Parkinson’s disease–a meta-analysis. Ann Clin Transl Neurol. 2017;4(3):212–6.CrossRef
22.
Liu Y, Sheikh MS. Melanoma: molecular pathogenesis and therapeutic management. Mol Cell Pharmacol. 2014;6(3):228.PubMedPubMedCentral
23.
Rastrelli M, Tropea S, Rossi CR, Alaibac M. Melanoma: epidemiology, risk factors, pathogenesis, diagnosis and classification. In Vivo. 2014;28:1005–11.PubMed
24.
Liu R, Gao X, Lu Y, Chen H. Meta-analysis of the relationship between Parkinson disease and melanoma. Neurology. 2011;76(23):2002–9.CrossRef
25.
Bertoni JM, Arlette JP, Fernandez HH, Fitzer-Attas C, Frei K, Hassan MN, et al. Increased melanoma risk in Parkinson disease: a prospective clinicopathological study. Arch Neurol. 2010;67(3):347–52.CrossRef
26.
Gao X, Simon KC, Han J, Schwarzschild MA, Ascherio A. Genetic determinants of hair color and Parkinson’s disease risk. Ann Neurol. 2009;65:76–82.CrossRef
27.
Pan T, Zhu J, Hwu W-J, Jankovic J. The role of α-synuclein in melanin synthesis in melanoma and dopaminergic neuronal cells. PLoS One. 2012;7:e45183.CrossRef
28.
Pfeiffer RF. Management of autonomic dysfunction in Parkinson’s disease. Semin Neurol. 2017;37(02):176–85 Thieme Medical Publishers.CrossRef
29.
Zhao CY, Murrell DF. Advances in understanding and managing bullous pemphigoid. F1000Res. 2015;4:F1000 1–7.
30.
Langan SM, Smeeth L, Hubbard R, Fleming KM, Smith CJP, West J, et al. Bullous pemphigoid and pemphigus vulgaris—incidence and mortality in the UK: population based cohort study. BMJ. 2008;337:a180.CrossRef
31.
Joly P, Baricault S, Sparsa A, Bernard P, Bédane C, Duvert-Lehembre S, et al. Incidence and mortality of bullous pemphigoid in France. J Investig Dermatol. 2012;132(8):1998–2004.CrossRef
32.
Cordel N, Chosidow O, Hellot MF, Delaporte E, Lok C, Vaillant L, et al. Neurological disorders in patients with bullous pemphigoid. Dermatology. 2007;215:187–91.CrossRef
33.
•• Brick KE, Weaver CH, Savica R, Lohse CM, Pittelkow MR, Boeve BF, et al. A population-based study of the association between bullous pemphigoid and neurologic disorders. J Am Acad Dermatol. 2014;71(6):1191–7 A case control and retrospective review which demonstrates a significantly increased risk of bullous pemphigoid development in those patients previously diagnosed with any type of neurological disorder. CrossRef
34.
Milani-Nejad N, Zhang M, Kaffenberger J. The association between bullous pemphigoid and neurological disorders: a systematic review. Eur J Dermatol. 2017;27(5):472–81.PubMed
35.
Chen J, Li L, Chen J, Zeng Y, Xu H, Song Y, et al. Sera of elderly bullous pemphigoid patients with associated neurological diseases recognize bullous pemphigoid antigens in the human brain. Gerontology. 2011;57(3):211–6.CrossRef
36.
Bastuji-Garin S, Joly P, Lemordant P, et al. Risk factors for bullous pemphigoid in the elderly: a prospective case-control study. J Investig Dermatol. 2011;131:637–43.CrossRef
37.
Tarazona MJM, Mota ANC de M, Gripp AC, Unterstell N, Bressan AL. Bullous pemphigoid and neurological disease: statistics from a dermatology service. An Bras Dermatol. 2015;90(2):280–2.CrossRef
38.
•• Försti A-K, Jokelainen J, Ansakorpi H, et al. Psychiatric and neurological disorders are associated with bullous pemphigoid – a nationwide Finnish Care Register study. Sci Rep. 2016;6:37125 A nationwide Finnish retrospective review which demonstrates a nearly six times odds ratio increase of bullous pemphigoid development after diagnosis of multiple sclerosis. CrossRef
39.
Rodríguez-Leyva I, Chi-Ahumada EG, Carrizales J, et al. Parkinson disease and progressive supranuclear palsy: protein expression in skin. Ann Clin Transl Neurol. 2016;3(3):191–9.CrossRef
40.
Siepmann T, Penzlin AI, Illigens BM-W, Reichmann H. Should skin biopsies be performed in patients suspected of having Parkinson’s disease? Parkinsons Dis. 2017:1–6.CrossRef
41.
Langan SM, Groves RW, West J. The relationship between neurological disease and bullous pemphigoid: a population-based case–control study. J Investig Dermatol. 2011;131(3):631–6.CrossRef
Metadaten
Titel
Skin Disease and Neurological Conditions of the Elderly
verfasst von
John Tanaka
Christopher Henderson
Matilda W. Nicholas
Publikationsdatum
03.10.2018
Verlag
Springer US
Erschienen in
Current Geriatrics Reports / Ausgabe 4/2018
Elektronische ISSN: 2196-7865
DOI
https://doi.org/10.1007/s13670-018-0263-z

Weitere Artikel der Ausgabe 4/2018

Current Geriatrics Reports 4/2018 Zur Ausgabe

Dermatology and Wound Care (C Sayed and D Culton, Section Editors)

Infestations in the Geriatric Patient

Geriatric Orthopedics (E Meinberg, Section Editor)

Fragility Fractures in the Developing World: a Rising Challenge

Dermatology and Wound Care (C Sayed and D Culton, Section Editors)

Stasis Dermatitis: Differentiation from Other Common Causes of Lower Leg Inflammation and Management Strategies

Geriatric Orthopedics (E Meinberg, Section Editor)

Current Evaluation and Management of Vertebral Compression Fractures

Nutrition, Obesity and Diabetes (L Falque-Madrid and H Florez, Section Editors)

Multilevel Risk Factors Associated with Obesity in Older Latinos Ages 65 Years and Over

Geriatric Orthopedics (E Meinberg, Section Editor)

Minimally Invasive Osteosynthes of Periprosthetic Fractures in the Lower Extremity

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 | Hypertonie | Nachrichten

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 | Nierenkarzinom | Nachrichten

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 | NSCLC | Nachrichten

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC
weitere anzeigen

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise